Explainer
How Long Does Naltrexone Take to Work?
When naltrexone starts acting, what the first days and weeks of trials show, and when guidelines say to judge whether it is working.
By Naltrexone Reviews Editorial TeamUpdated 18 sourcesHow we check

On this page
Short answer
A naltrexone tablet reaches its peak blood level within an hour and blocks opioids from the first dose.1 In alcohol use disorder, one trial of the monthly shot found less drinking than on placebo from day 2 (a post hoc analysis). Guidelines judge it at 4 to 6 weeks (NICE) or 3 months (VA/DoD).2-4
Asking how long it lasts after a dose, or how long a drug test can find it? That is covered on how long naltrexone stays in your system.
Key takeaways
- The early drinking data come from one trial of the Vivitrol shot, analysed after the fact. Most people in it were still drinking at the first injection, and the Vivitrol label reports that its drinking-day effects were not evident in that group.2,5
- We found no tablet trial in people seeking treatment that reports a day-by-day start. The closest data are a 6-day lab study and a 3-week trial, both in people with drinking problems who were not seeking treatment.6,7
- Tablet levels peak within an hour and do not build up, so there is no waiting period for the drug itself. Whether it is helping your drinking is judged at 4 to 6 weeks (NICE) or 3 months (VA/DoD).1,3,4
- Nausea, the side effect that most often made people stop in a large safety study, tends to start early in treatment.1,8
Timeline: first dose to month 6
| When | What is known | Type of evidence |
|---|---|---|
| First hour | Tablet: naltrexone and its active metabolite, 6-β-naltrexol, peak in the blood within 1 hour1 | FDA label |
| First 24 hours | One 50 mg tablet blocks the effects of 25 mg of injected heroin for up to 24 hours. The shot's first blood-level peak comes about 2 hours after the injection1,5 | FDA labels |
| Days 2 to 3 (shot) | Second blood-level peak. Compared with placebo, people on the 380 mg shot drank fewer drinks per day by day 2, and fewer reported heavy drinking by day 32,5 | Label; one trial, post hoc analysis |
| Days 1 to 7 (tablet) | In a lab study of 18 volunteers, 6 days of 50 mg a day lowered craving and the number of drinks chosen in a drinking session, compared with placebo6 | Lab study, not a treatment trial |
| Weeks 1 to 3 (tablet) | In 180 heavy drinkers, 3 weeks of 50 mg a day lowered the share of days with any drinking, compared with placebo7 | One randomized trial, people not seeking treatment |
| First month (shot) | 37% fewer heavy drinking days than placebo2 | One trial, post hoc analysis |
| Weeks 4 to 6 | NICE: stop the tablets if drinking persists 4 to 6 weeks after starting3 | Guideline (England) |
| 3 months | The tablet trials behind the US label ran 12 weeks. VA/DoD: stop and consider other options if 50 mg a day for 3 months brings no detectable benefit1,4 | FDA label; guideline (US) |
| 6 months and beyond | NICE: usually prescribed for up to 6 months, or longer for people who benefit and want to continue. In the shot trial, the day-3 drop in the share of people reporting heavy drinking held through 24 weeks2,3 | Guideline; one trial |
What is known about naltrexone from the first dose to month 6, and the kind of evidence behind each row.
When: First hour
- What is known
- Tablet: naltrexone and its active metabolite, 6-β-naltrexol, peak in the blood within 1 hour1
- Type of evidence
- FDA label
When: First 24 hours
When: Days 2 to 3 (shot)
When: Days 1 to 7 (tablet)
- What is known
- In a lab study of 18 volunteers, 6 days of 50 mg a day lowered craving and the number of drinks chosen in a drinking session, compared with placebo6
- Type of evidence
- Lab study, not a treatment trial
When: Weeks 1 to 3 (tablet)
- What is known
- In 180 heavy drinkers, 3 weeks of 50 mg a day lowered the share of days with any drinking, compared with placebo7
- Type of evidence
- One randomized trial, people not seeking treatment
When: First month (shot)
- What is known
- 37% fewer heavy drinking days than placebo2
- Type of evidence
- One trial, post hoc analysis
When: Weeks 4 to 6
- What is known
- NICE: stop the tablets if drinking persists 4 to 6 weeks after starting3
- Type of evidence
- Guideline (England)
When: 3 months
When: 6 months and beyond
No build-up phase: the block starts with the first dose
Naltrexone is absorbed almost completely from the gut and blocks opioid receptors on the day you take it. Daily tablets do not pile up in the body either: blood levels did not accumulate on 100 mg a day.1
Because the block is immediate, anyone with opioids in their body can go into sudden withdrawal on the first dose. After short-acting opioids, the label asks for an opioid-free gap of at least 7 to 10 days.1 The details are on naltrexone dosage.
For alcohol, the label says the mechanism "is not understood," though preclinical data point to the body's own opioid system.1 In a 1992 trial of 70 men, the difference showed up mainly after a first slip (the relapse figures).9 J.D. Sinclair, after whom the Sinclair method is named, proposed that each drink taken while the reward is blocked weakens the urge a little, which he called extinction.10 That is a hypothesis, not a proven mechanism. The Sinclair method page covers it.
Your drinking log shows whether it is working
The trials on this page measured heavy drinking days, drinks per day and days with any drinking.2,7 In the Vivitrol trial, a heavy drinking day meant 5 or more standard drinks for men and 4 or more for women.5 So the most useful check is a written count: note each day's drinks from the first dose and bring the log to follow-up visits.
A 6-day lab study suggests what to look for. The first drink felt the same on naltrexone as on placebo; the difference came after it, with fewer and slower drinks and less craving.6 A first drink that feels unchanged does not mean the drug has failed.
Daily pill-taking matters too. In two trials the benefit was larger in people who took their tablets reliably, though those groups were not randomized (pill-taking).11,12 MedlinePlus adds that naltrexone helps only while you keep taking it.13
The fastest data come from the shot, in one trial
The early-response figures come from a post hoc analysis of the 24-week Vivitrol trial: a look back at data the trial was not set up to test.2,14 The trial gave monthly shots plus counseling to 624 alcohol-dependent adults, most of them still drinking at the first shot, and the 380 mg dose cut the rate of heavy drinking days by 25% compared with placebo over the whole trial.14
Three limits apply to the early finding:
- It is one trial. A second paper on the same trial, looking at 82 people who had already stopped drinking for at least 4 days, is the same evidence, not a new study.15
- The label narrowed who it applies to. The Vivitrol label reports greater drops in drinking days and heavy drinking days among the 8% who had stopped drinking the week before the first shot, and says the same effects were not evident in the 92% who were actively drinking. The label says people should not be actively drinking at the first injection.5
- It does not transfer to tablets. After a shot, naltrexone stays measurable for more than a month, and one shot delivers 3 to 4 times the naltrexone of 28 days of 50 mg tablets.5
How the shot and the tablets compare on cost and use is on naltrexone vs Vivitrol, and the shot itself is covered on Vivitrol.
Guidelines judge it at 4 to 6 weeks or 3 months
The US tablet label sets no checkpoint. Its alcohol trials used 50 mg a day for up to 12 weeks, and other durations were not tested.1 The two guidelines that do give one differ:
- NICE (England, 2011): stop oral naltrexone if drinking persists 4 to 6 weeks after starting. NICE wrote this for people starting after assisted withdrawal.3
- VA/DoD (US, 2021): stop and consider other options if there is no detectable benefit after 50 mg a day for 3 months. For the shot, the cut-off is no detectable benefit within 3 months.4
Stopping is not the only choice. Raising the dose, more check-ins, different counseling or a switch are covered in what to do if you are still drinking heavily. The other medicines are compared on naltrexone vs acamprosate and naltrexone vs disulfiram. Whether it works at all, and for whom, is on does naltrexone work?
Side effects tend to come in the first weeks
In a 12-week open-label study of about 570 people taking the tablets for alcohol, 10% had new nausea and 7% new headache.1,8 Nausea was the most common reason the 15% who stopped for side effects gave up the drug.8 In a study of 120 people that rated side effects after 1 week, 15% had moderate or severe nausea in that week. It was tied to missed doses and heavier drinking, and was less likely in people who had been sober longer before starting.16 In a 128-person trial, people with more or worse side effects in their first week, especially nausea and fatigue, were more likely to drop out early.17
With the shot, nausea after the first injection tends to be mild and to ease within a few days.5 Rates compared with placebo are on naltrexone side effects.
Early side effects, mostly nausea and headache, typically settle within 1 to 2 weeks, and the VA/DoD guideline suggests taking each dose with food.4 The opioid check, starting dose, timing and when to call are in starting naltrexone: the first two weeks.
Weight loss and low-dose naltrexone run on other clocks
Weight loss. The 50 mg tablet's label covers alcohol and opioid use only.1 The approved weight-loss product, Contrave, combines naltrexone with bupropion. Its label says to check the result after 12 weeks on the full dose and to stop if weight has not dropped by at least 5%.18 Naltrexone and bupropion (Contrave) covers it.
Low-dose naltrexone (LDN). LDN uses doses far below the 50 mg tablet and is off-label. Its evidence, and its own timing questions, are on low-dose naltrexone.
Your experience: If you've started naltrexone, you can tell us what your first weeks were like. Stories appear on naltrexone reviews only with permission.
Frequently asked questions
Does naltrexone build up in your system?
No. Tablet levels peak within an hour, and daily doses do not accumulate. See no build-up phase.1
How do I know if naltrexone is working?
Count your drinks. Trials judge it by heavy drinking days and drinks per day, so a written daily log is the clearest check. See your drinking log.2
Does the Vivitrol shot work faster than the pills?
Only the shot has early-response data: drinking dropped from day 2 in one trial whose participants were mostly still drinking at the start. See the shot data.2
What time of day should I take naltrexone?
The tablet label names no time. MedlinePlus says to take it once a day at about the same time, with or without food. See morning or night.13
How long does naltrexone take to work for weight loss?
For Contrave, the label judges it at 12 weeks on the full dose. See weight loss.18
How we checked
- Timing figures come from the current tablet, Vivitrol and Contrave labels, NICE CG115 and the VA/DoD 2021 guideline, checked against saved copies on October 17, 2026.1,3-5,18
- Trial and lab figures come from the PubMed abstracts of 11 papers, listed in the references; we haven't read the full texts, so day-by-day drink counts are not shown.
- Ciraulo 2008 and O'Malley 2007 both analyze the Garbutt 2005 trial and count as one trial.
Related guides
- Naltrexone for alcohol use disorder
- Does naltrexone work?
- What happens if you drink on naltrexone?
- Naltrexone vs disulfiram
- How long does naltrexone stay in your system?
- Naltrexone side effects
- Naltrexone dosage
- Vivitrol
- Naltrexone vs Vivitrol
- The Sinclair method
- Low-dose naltrexone
- where to get naltrexone online
- Naltrexone
References
18 sources, numbered in the order they are first cited (AMA style). Each is labelled by type so you can weigh it; commercial and media sources are never the only support for a clinical claim.
- 1.Naltrexone hydrochloride tablets USP, 50 mg. Prescribing information. SpecGx LLC; revised May 2026. DailyMed SPL version 15. Accessed October 17, 2026. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=06ff2d5a-e62b-4fa4-bbdb-01938535bc65FDA drug label
- 2.Ciraulo DA, Dong Q, Silverman BL, Gastfriend DR, Pettinati HM. Early treatment response in alcohol dependence with extended-release naltrexone. J Clin Psychiatry. 2008;69(2):190-195. doi:10.4088/jcp.v69n0204Research study · Our summary of this study
- 3.National Institute for Health and Care Excellence. Alcohol-Use Disorders: Diagnosis, Assessment and Management of Harmful Drinking (High-Risk Drinking) and Alcohol Dependence. Clinical guideline CG115. Published February 23, 2011. Updated October 21, 2014. Accessed October 17, 2026. https://www.nice.org.uk/guidance/cg115/chapter/RecommendationsClinical guideline
- 4.US Department of Veterans Affairs; US Department of Defense. VA/DoD Clinical Practice Guideline for the Management of Substance Use Disorders. Version 5.0. 2021. Accessed October 17, 2026. https://www.healthquality.va.gov/HEALTHQUALITY/guidelines/MH/sud/VA-DoD-SUD-CPG_Final_for-508_v3.pdfClinical guideline
- 5.Vivitrol (naltrexone for extended-release injectable suspension). Prescribing information. Alkermes, Inc.; revised May 2026. DailyMed SPL version 39. Accessed October 17, 2026. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=cd11c435-b0f0-4bb9-ae78-60f101f3703fFDA drug label
- 6.O'Malley SS, Krishnan-Sarin S, Farren C, Sinha R, Kreek MJ. Naltrexone decreases craving and alcohol self-administration in alcohol-dependent subjects and activates the hypothalamo-pituitary-adrenocortical axis. Psychopharmacology (Berl). 2002;160(1):19-29. doi:10.1007/s002130100919Randomized controlled trial · Our summary of this study
- 7.Tidey JW, Monti PM, Rohsenow DJ, et al. Moderators of naltrexone's effects on drinking, urge, and alcohol effects in non-treatment-seeking heavy drinkers in the natural environment. Alcohol Clin Exp Res. 2008;32(1):58-66. doi:10.1111/j.1530-0277.2007.00545.xResearch study · Our summary of this study
- 8.Croop RS, Faulkner EB, Labriola DF. The safety profile of naltrexone in the treatment of alcoholism: results from a multicenter usage study. Arch Gen Psychiatry. 1997;54(12):1130-1135. doi:10.1001/archpsyc.1997.01830240090013Research study · Our summary of this study
- 9.Volpicelli JR, Alterman AI, Hayashida M, O'Brien CP. Naltrexone in the treatment of alcohol dependence. Arch Gen Psychiatry. 1992;49(11):876-880. doi:10.1001/archpsyc.1992.01820110040006Randomized controlled trial · Our summary of this study
- 10.Sinclair JD. Evidence about the use of naltrexone and for different ways of using it in the treatment of alcoholism. Alcohol Alcohol. 2001;36(1):2-10. doi:10.1093/alcalc/36.1.2Narrative review · Narrative review written by the method's developer.
- 11.Volpicelli JR, Rhines KC, Rhines JS, Volpicelli LA, Alterman AI, O'Brien CP. Naltrexone and alcohol dependence: role of subject compliance. Arch Gen Psychiatry. 1997;54(8):737-742. doi:10.1001/archpsyc.1997.01830200071010Randomized controlled trial · Our summary of this study
- 12.Baros AM, Latham PK, Moak DH, Voronin K, Anton RF. What role does measuring medication compliance play in evaluating the efficacy of naltrexone? Alcohol Clin Exp Res. 2007;31(4):596-603. doi:10.1111/j.1530-0277.2007.00343.xResearch study · Our summary of this study
- 13.Naltrexone. MedlinePlus. US National Library of Medicine. Updated September 15, 2026. Accessed October 17, 2026. https://medlineplus.gov/druginfo/meds/a685041.htmlGovernment source
- 14.Garbutt JC, Kranzler HR, O'Malley SS, et al. Efficacy and tolerability of long-acting injectable naltrexone for alcohol dependence: a randomized controlled trial. JAMA. 2005;293(13):1617-1625. doi:10.1001/jama.293.13.1617Randomized controlled trial · Our summary of this study
- 15.O'Malley SS, Garbutt JC, Gastfriend DR, Dong Q, Kranzler HR. Efficacy of extended-release naltrexone in alcohol-dependent patients who are abstinent before treatment. J Clin Psychopharmacol. 2007;27(5):507-512. doi:10.1097/jcp.0b013e31814ce50dResearch study · Our summary of this study
- 16.O'Malley SS, Krishnan-Sarin S, Farren C, O'Connor PG. Naltrexone-induced nausea in patients treated for alcohol dependence: clinical predictors and evidence for opioid-mediated effects. J Clin Psychopharmacol. 2000;20(1):69-76. doi:10.1097/00004714-200002000-00012Research study · Our summary of this study
- 17.Rohsenow DJ, Colby SM, Monti PM, et al. Predictors of compliance with naltrexone among alcoholics. Alcohol Clin Exp Res. 2000;24(10):1542-1549.Research study · Our summary of this study
- 18.Contrave (naltrexone hydrochloride and bupropion hydrochloride) extended-release tablets. Prescribing information. Nalpropion Pharmaceuticals LLC; revised November 2025. DailyMed SPL version 27. Accessed October 17, 2026. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=485ff360-32c8-11df-928b-0002a5d5c51bFDA drug label
Medical disclaimer
This page is for general information only and is not medical advice. It does not replace advice from your own clinician or pharmacist. Don't start, stop or change a medicine or dose without talking to your prescriber. If you are physically dependent on alcohol, stopping suddenly can be dangerous; get medical advice first. If you use opioids, starting naltrexone in either form can cause sudden, severe withdrawal.
Full medical disclaimer.